A detailed history of Nisa Investment Advisors, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 139 shares of NAUT stock, worth $244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
139
Previous 202 31.19%
Holding current value
$244
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$2.24 - $3.08 $141 - $194
-63 Reduced 31.19%
139 $0
Q2 2024

Jul 19, 2024

BUY
$2.22 - $3.0 $415 - $561
187 Added 1246.67%
202 $0
Q4 2023

Jan 25, 2024

SELL
$2.34 - $3.39 $20,989 - $30,408
-8,970 Reduced 99.83%
15 $0
Q2 2023

Aug 11, 2023

BUY
$2.21 - $4.52 $17,171 - $35,120
7,770 Added 639.51%
8,985 $34,000
Q1 2023

May 02, 2023

BUY
$1.67 - $2.77 $2,004 - $3,324
1,200 Added 8000.0%
1,215 $3,000
Q4 2022

Feb 02, 2023

BUY
$1.55 - $2.47 $23 - $37
15 New
15 $0

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $219M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.